Corrigendum to “Corneal bioprinting using a high concentration pure collagen I transparent bioink” [Bioprinting 28 (2022) e00235] (Bioprinting (2022) 28, (S2405886622000458), (10.1016/j.bprint.2022.e00235))
The authors regret that the financial disclosure was not included in the first publication. The financial disclosure is now added. The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: the content of collagen I printing and gel formation was captured in The collagen gel formulations patent (WO/2021/097524) with YS, GS, JY being inventors. The authors would like to apologise for any inconvenience caused.
Open Access Status
This publication may be available as open access